Patents Assigned to Rascal Therapeutics, Inc.
  • Compounds and compositions for the treatment of cancer
    Patent number: 12227482
    Abstract: The present disclosure provides compounds, pharmaceutical compositions, and methods for the treatment of cancer and fibrosis. The disclosed pharmaceutical compositions may include one or more pyrazolyl-containing compounds, or a derivative thereof.
    Type: Grant
    Filed: December 5, 2022
    Date of Patent: February 18, 2025
    Assignees: The Regents of the University of California, Rascal Therapeutics, Inc.
    Inventors: Csaba Peto, Bhairavi Tolani, Gavitt Woodard, Tsze Tsang, Michael Mann, David M. Jablons, Biao He